Preventing Disease with Adolescent Immunizations - PowerPoint PPT Presentation

1 / 57
About This Presentation
Title:

Preventing Disease with Adolescent Immunizations

Description:

Preventing Disease with Adolescent Immunizations Nancy Rudner Lugo, DrPH, NP * * * * * * * * * * * * * * * * * * Nancy Rudner Lugo, DrPH, NP * Tdap-tetanus ... – PowerPoint PPT presentation

Number of Views:173
Avg rating:3.0/5.0
Slides: 58
Provided by: Pam96
Category:

less

Transcript and Presenter's Notes

Title: Preventing Disease with Adolescent Immunizations


1
Preventing Disease with Adolescent Immunizations
  • Nancy Rudner Lugo, DrPH, NP

2
Even 2,500 Years Ago, People Knew Immunity
Worked.
  • 500 BC Greece
  • Observation people who survived smallpox never
    got the disease again.
  • The insight Surviving smallpox infection
    protects against further infections---give
    immunity.

3
  • Until mid 20th century, infectious diseases were
    the leading cause of death
  • Jenners small pox innoculations from cowpox
    (cowsvacas) and from smallpox patient scabs

4
Life Expectancy
5
Healthy People 2010 objectives
Reduction in Vaccine-Preventable Diseases 1998 Baseline 2010 Target
Reduction in Vaccine-Preventable Diseases Number of Cases Number of Cases
Congenital rubella syndrome (lt 1 year) 7 0
Diphtheria (persons under age 35 years) 1 0
Haemophilus influenzae type b ( lt 5 years) 163 0
Hepatitis B (2 to 18 years) 945 9
Measles (persons of all ages) 74 0
Mumps (persons of all ages) 666 0
Pertussis (children lt age 7 years) 3,417 2,000
Polio (wild-type virus) (persons of all ages) 0 0
Rubella (persons of all ages) 364 0
Tetanus (persons lt age 35 years) 14 0
Varicella (chicken pox) (persons lt 18 years) 4 million 400,000
6
SUCCESS Reducing VPD
Disease Maximum Cases 2001
Change()
Diphtheria 206,939 2 -99.99
Measles 894,134 108 -99.99
Mumps 152,209 231 -99.60 Polio
21,269 0 -100.00 Rubella
57,686 19 -99.40 Congenital
rubella syndrome 20,000 2
-99.97 Tetanus 1,733 27
-98.04 HIB (lt5 years) 20,000 183
-99.25 Smallpox 58,000
0 -100.00 Hepatitis B 200,500
80,000
-60.00 Pertussis 265,269 5,396
-97.63 Varicella
83,500 14,980
-82.00 Pneumoccocal Disease
15,933 14, 008 ----------
7
Quick review-How do vaccine work?
  • Antigen causes antibody formation, without
    causing full disease
  • Killed or Live attenuated (live and weakened)
    viruses stimulate body to make antibodies and
    develop immunologic memory. Body will recognize
    virus/bacteria and fight it off microbe cannot
    replicate in vaccinated body
  • Community Immunity so many people immune that
    virus cannot spread. Usually needs 90 immunity

8
Immunization schedules
  • Determined by Advisory Committee on Immunization
    Practices (ACIP)
  • Revised December each year
  • Always be sure you are using the most current
    schedule (www.cdc.gov/vaccines)
  • 3 schedules Child, 7-18 y.o (not called
    adolescent since could not agree to who is an
    adolescent), adult

9
Assess IZ needs every adolescent, every adult,
every visit
  1. Assess immunization needs for
  2. Catch up missing childhood immunizations
  3. Age specific immunization
  4. Risk-based immunizations
  5. Travel immunizations
  6. Assess every patient, every time

10
Lets get to the details
  • Who gets what vaccine,
  • why and when??

11
First, what about you?Vaccines for health care
personnel
  • Influenza, annually- to protect HCP, their
    families, and patients
  • Rubella to protect HCP and babies
  • Pertussis- protect HCP and babies
  • Hepatitis B-to protect HCP from BBP

12
11-12 year old visit-
  • A great time to
  • assess growth and development
  • provide anticipatory guidance
  • reaffirm provider-patient/family relationship
  • assess need for catch up immunizations
  • give age-specific immunizations
  • New immunizations added to 11-12 y .o visit

13
Adolescent Immunizations
  • Catch up immunizations-
  • check for completion of pediatric vaccinations-
  • Hep B, MMR, varicella, IPV series
  • Immunizations for adolescents
  • HPV to prevent cervical cancer (series of 3)
  • MCV4 to prevent meningoccocal infection
  • Tdap as adol. tetanus, diphtheria, and pertussis
    booster
  • Influenza each year
  • Immunization for at risk pneumo, hep A, travel

14
Catch Up-Hepatitis B
  • Most teens have completed series
    prior to kindergarten
  • Adolescence can be Hep B risky
  • Hepatitis B infection can lead to hep CA
  • Give IM,
  • Engerix 3 doses over 6 months
  • OR Recombivax , 2 doses 4-6 months apart
  • If started but did not finish series, do NOT
    start series over.

15
measles
16
mumps
17
Catch UP-MMR
  • Needs 2 doses after age 1, at least 4 weeks apart
  • Do not give if pregnant or will be pregnant in 3
    months
  • Do not use MMRV after age 13
  • Live vaccine, given SC

18
Varicella
19
Catch UP-varicella
  • Varicella-
  • Unimmunized, no history of disease-Adolescents
    need two doses SC
  • 4-8 weeks apart
  • Temperature sensitive- in freezer
  • Do not use MMRV gt13 y.o.
  • Outbreaks in immunized, reduced w booster

20
Catch Up-IPV
  • Series of 3, at 0,1, and 6-12 months
  • Everyone lt18 y.o should finish series
  • If started but did not finish series, give what
    is needed do not restart series
  • Global goal to eradicate polio. Especially a
    challenge is areas of distrust and/or war

21
Wild Poliovirus 2001
494 confirmed cases worldwide
22
Adolescent Immunizations
  • Catch up immunizations-
  • check for completion of pediatric vaccinations-
  • Hep B, MMR, varicella, IPV series
  • Immunizations for adolescents
  • HPV to prevent cervical cancer
  • MCV4 to prevent meningoccocal infection
  • Tdap as adol. tetanus, diphtheria, and pertussis
    booster
  • Immunization for at risk pneumo, influenza, hep
    A
  • Travel immunizations prn

23
Human Papilloma Virus
  • Major cause of cervical and anogenital cancer
  • In U.S. 11,150 new cases of cervical cancer each
    year
  • Globally, 500,000 (a half million) new cases each
    year
  • 50 of women have HPV 4 years after first
    intercourse most infections are transient,
    asymptomatic healthy immune system clears the
    infection

24
Human Papilloma Virus
  • Persistant infection may
    lead to cancer
  • HPV strains 16, 18 cause 80 of cervical cancer
  • HPV strains 6,11 cause most venereal warts

25
Human Papilloma Virus
  • 1 in 3 women will have an abnormal Pap test in
    her lifetime
  • Abnormal Paps may require further evaluation and
    treatment, such as culposcopy, cyrosurgery
  • 4 billion spent on Pap management annually
  • Screening has its challenges
  • Over 50 of women with cervical cancer have never
    had a Pap test
  • Follow up for abnormal Paps can be difficult

26
HPV vaccines
  • Guardasil HPV 6,11, 16,18
  • Approved ages 9-26
  • Cervarix (not yet approved), HPV 16,18
  • 3 shots, 0,2,6 months, IM in deltoid
  • 4 weeks between doses 1 and 2 12 weeks between
    doses 2 and 3
  • Made w VLPs-viral like particles

27
HPV vaccine
  • Recommended for 11-12 y.o., prior to sexual debut
    and in sync with other 11-12 y.o IZ
  • 26 females age 15, 49 age 17 have had
    intercourse
  • Approved for ages 9-26
  • OK for women who have had multiple partners and
    women with abnormal Paps. Protects against at
    least 2 strains, so may be infected w one and can
    benefit from vaccine
  • Potential to reduce cervical cancer incidence by
    70
  • Still need Pap tests

28
Should I give HPV when.
  • Abnormal Pap or positive HPV test- still give HPV
    vaccine. DK which strain of HPV caused abnormal
    Pap
  • Pregnancy-avoid giving immunization no data
  • Immunosuppression- ok to give HPV
  • Breastfeeding- ok to give

29
Meningococci
  • Can cause devastating neurological damage,
    encephalitis, death. Rare but devastating
  • Case fatality 10-14
  • 11-19 cases have severe sequelae-
  • e.g. loss of limbs, hearing, seizures
  • Peak incidence and mortality age 15-24
  • Current vaccines-strains A C Y W-135 which cause
    80 of meningitis but not B (which mostly infects
    younger children)

30
Meningococci Transmission
  • 5-10 of the population carries meningococci
  • Adolescents and young adults most frequent
    carriers few carriers develop disease
  • Transmission via air droplets, secretions from
    infected person

31
Meningococcal Vaccine
  • ACIP recommendation
  • MCV4 (conjugate) at the 11-12 years old visit.
  • Conjugate duration approx 10 years
  • Unimmunized college freshmen should be immunized
  • Prior to availability of conjugate meningococcal
    vaccine, polysacchride-shorter duration--given
    just before college
  • Young adults (18-24 y.o.) living in aggregate
    housing such as dormitories or military barracks
    are at higher risk for meningococcal disease.

32
tetanus
33
Bordetella pertussis
  • Spreads by droplet--through the air by infectious
    droplets
  • AKA whooping cough (go to pertussis.com to hear
    it)
  • Also known as 100 day cough
  • Highly contagious
  • Only VPD in US on the rise
  • (gt25,000 cases of pertussis in US 2004-05)
  • The incubation period is 5-10 days, upper limit
    21 days
  • Most pertussis deaths in U.S. are in infants too
    young to complete series, most infected by family
    member
  • Antibiotics if given early enough can shorten
    course and spread.

34
Tdap-tetanus, diphtheria, pertussis
  • Tdap has different amounts than DTaP
  • (Beware look alikes!)
  • Two Tdap products
  • Adacel approved for 11-64 y.o.
  • Boostrix approved for 10-18 y.o.
  • ACIP recommendations
  • all11-12 y.o.
  • gt 12 y.o if have not had it
  • Adults lt65 y.o. (Adacel only) in contact w
    infants lt12 months old
  • Routine interval- 5 years after Td no minimum
    interval

35
Tdap
  • Pregnancy not contraindicated, but Td
    recommended by ACIP
  • Breastfeeding- yes
  • Immunosuppressed- yes

36
Adolescent Immunizations
  • Catch up immunizations-
  • check for completion of pediatric vaccinations-
  • Hep B, MMR, varicella, IPV series
  • Immunizations for adolescents
  • HPV to prevent cervical cancer
  • MCV4 to prevent meningoccocal infection
  • Tdap as adol. tetanus, diphtheria, and pertussis
    booster
  • Immunization for at risk
  • pneumo, influenza, hepatitis A
  • Travel immunizations

37
Pneumonia and influenza vaccines for those w
risks
  • Chronic conditions made worse by infection
  • Respiratory (e.g. asthma)
  • Metabolic (eg diabetes)
  • Cardiovascular
  • Renal dysfunction
  • Neurological disorder impairing ability to handle
    secretions

38
Influenza
  • Influenza is serious infection, causing
    hospitalizations and 135,000 deaths/yearMost
    morbidity and mortality is among young, old, ill
  • Common infection
  • Strain changes each year, need annual vaccination

39
Influenza
  • Recommended for
  • ages 6 months to 18 years
  • gt50 y.o.
  • ANYONE who does not want to get influenza!
  • 2 forms
  • Injectible
  • Intranasal -LAIV-For healthy 5-49 y.o. with no
    influenza risk factors

40
Hepatitis A
41
Hepatitis A Virus (HAV)
  • Spread by fecal oral route
  • Unwashed hands preparing food, contaminated water
  • Unwashed fruit or other food
  • close personal contact with an infected person
  • Crack users share rocks with dirty hands
  • Children can be asymptomatic and spread (think
    diapers)
  • 100 deaths/year in US from fulminating liver
    destruction. Most have history of liver
    impairment
  • HAV vaccine recommended for all 1-2 y.o., all at
    risk-
  • MSM, travel to endemic areas, liver disease
  • Series of 2, 6 months apart

42
Vaccine-preventable adult diseases
  • Diphtheria
  • Haemophilus influenzae type b(Hib)
  • Hepatitis A
  • Hepatitis B
  • Herpes Zoster (Shingles)
  • Human Papillomavirus (HPV)
  • Influenza(flu)
  • Measles
  • Meningococcal
  • Mumps
  • Pertussis (whooping cough)
  • Pneumococcus
  • Polio
  • Rubella (German measles)
  • Tetanus (lockjaw)
  • Varicella (chickenpox)

43
Contraindicated in Pregnancy
  • MMR
  • Varicella

44
Hepatitis A and B risks
  • Hepatitis A
  • MSM
  • drug users (not just IV)
  • Male prison inmates
  • Chronic liver disease
  • Heavy drinkers
  • Dialysis
  • Travel to endemic areas
  • Hepatitis B
  • gt1 sex partner in 6 months
  • MSM
  • IV drug users
  • Male prison inmates
  • Chronic liver disease
  • dialysis

45
But how do you know who is at risk?
  • Risk-based immunizations underutilized
  • Screen questionnaires w option to select
    immunization without ID risk criteria

46
Missed Opportunities for Immunizations
  • Minor illness is NOT a contraindication
  • If one in a series of immunizations is missed
    (not given on the schedule), do NOT restart
    series continue the series.

47
Where to get immunizations
  • Health care home
  • Local health departments, often at much lower
    cost than private provider
  • Nurse Practitioners in retail settings
  • Health fairs
  • Employers
  • Pharmacies

48
Payment for adolescent and adult IZ
  • Adolescents
  • Most health plans cover ACIP recommended or
    school required IZ (but some have high
    deductible)
  • Vaccines for Children (VFC) ages 0-18 (to 19th
    birthday)
  • Payment for adult immunizations spotty
  • Health plans do not pay for work-related IZ

49
Immunization Process
  1. Assess immunization needs
  2. Educate the patient/family on IZ, S/E
  3. Screen for contraindications
  4. Prepare vaccine, select needle size
  5. Give immunization
  6. Document
  7. Schedule next immunization

50
Educate patient/family VISVaccine Information
Sheets
51
Immunization Process
  • Screen for contraindications
  • Egg allergy
  • Neomycin allergy
  • Previous reaction, such as temp gt 105 seizure or
    convulsion cried for 3 or more hours (child)
    needed medical care within 48 hours
  • Immunocompromised
  • Pregnancy- avoid live vaccines like MMR

52
Immunization Process
  • Prepare the vaccine
  • Follow manufacturer directions
  • If need to mix dilutent, use aseptic technique
  • Have process to identify which vaccine in which
    syringe

53
Immunization Process
  • Determine route and needle size
  • 5/8 length needle for SC,
  • IM needle length by age, size, route

54
Recommendations from Nurse Practitioner
Healthcare Foundation
  • To be released 2009
  • Raise awareness of the need for adolescent
    immunizations among 11-to 12-year-olds and their
    parents.
  • Communicate with adolescents in their own venues
    put messages where adolescents are and make it
    fashionable to get immunized.
  • Remove financial barriers.
  • Leverage health plans to encourage adolescent
    immunizations.
  •  

55
Recommendations from Nurse Practitioner
Healthcare Foundation
  • Encourage local, state, and national registries
    to include adolescent data.
  • Support multiple venues for immunization
    education and for the immunizations themselves.
  • Every healthcare practitioner needs to be current
    on immunizations.
  • Eliminate practice barriers to immunizations.

56
Vaccine Life Cycle
  • Image and content adapted fromChen RT, Rastogi
    SC, Mullen JR, Hayes S, Cochi SL, Donlon JA,
    Wassilak SG. The Vaccine Adverse Event Reporting
    System (VAERS). Vaccine 199412542-50., accessed
    Sept 4, 2007 from www.cdc.gov/vaccine

57
Great resources
  • www.immunize.org (Immunization Action Coalition)
  • www.cdc.gov/vaccines
  • www2a.cdc.gov/TCEOnline
  • Lots of great online and satellite training,
    including immunization updates, w CEU credits

58
Standards for Immunization Practice
  • Availability of vaccines
  • Vaccines are readily available
  • PCP, specialists, etc
  • Vaccines are coordinated with other health
    services and medical home
  • Barriers are identified and minimized
  • --scheduling, requiring WCC and PE, long waits
  • Patient costs are minimized

59
Standards for Immunization Practice
  • Assessment of vaccine status
  • Review IZ status every child, every time
  • Assess and follow only true contraindications

60
Standards for Immunization Practice
  • Effective communication about benefits and risks
  • Educate families
  • In easy to understand language
  • In culturally appropriate manner
  • Allow enough time
  • Give VIS
  • Address questions and concerns
  • Encourage families to inform of adverse events

61
Standards for Immunization Practice
  • Proper storage, administration and documentation
  • Follow storage and handling procedures
  • Note expiration date
  • Monitor and record temperature BID
  • Up-to-date written vaccination protocols
  • Current schedule, contraindications
  • Administration techniques
  • Storage and handling requirements
  • Treatment and reporting of adverse events
  • Benefit and risk communication
  • Vaccine record maintenance

62
Standards for Immunization Practice
  • Proper storage, administration and documentation
  • Ongoing education of staff
  • Current schedule, contraindications
  • Storage and handling requirements
  • Treatment and reporting of adverse events
  • Benefit and risk communication
  • Give as many indicated doses as possible in the
    same visit
  • Reduce need for more visits, risk of missed doses
  • Avoid delayed protection

63
Standards for Immunization Practice
  • Proper storage, administration and documentation
  • IZ records are accurate, complete, easily
    accessible
  • On a standard form
  • Document all vaccines received from you and other
    HCP
  • Report to registry
  • Give family hand-held record to bring to all hc
    encounters
  • Report adverse events promptly to VAERS-Vaccine
    Adverse Event Reporting System
  • All personnel who have contact with patients are
    appropriately vaccinated
  • Have systems in place to review and maintain IZ
    status of all personnel and trainees

64
Standards for Immunization Practice
  • Implement strategies to improve vaccination
    coverage
  • Systematic reminders and recall (SR)
  • Mailed, phone reminders and recall to families
  • Provider reminder/recall systems
  • Annual office/clinic patient record reviews
  • Practice community-based approaches
  • Work with partners (SR)
  • Develop strategies to meet community needs

65
  • An once of prevention is worth
Write a Comment
User Comments (0)
About PowerShow.com